This varies by peptide and goal
Weight Management and Retatrutide : Retatrutide has shown remarkable efficacy in weight management
In the United States, prescribing rules are more flexible
At present, relevant studies have confirmed that the expression of ALOX12 can reasonably predict the prognosis of patients, and ALOX12 can be used as a predictor of tumor prognosis [36,37,38]
Targeting cerebral incretin and insulin receptors appears to show promise for neurodegenerative conditions, perhaps through neuroprotective mechanisms including reducing cell death and inflammation whilst enhancing neurogenesis
Self-reported questionnaires for anthropometrics, demographics, dietary habits, and GLP-1RA usage were administered